Colon Cancer Symptoms - Genentech shares down, analyst cuts Lucentis
Genentech shares down, analyst cuts Lucentis
Reuters - Ophthalmologists are using Genentech Inc.’s (DNA.N: , , ) cancer drug Avastin to treat a major cause of as an intravenous treatment for colon cancer, has been shown to fight
Woman cycling around the world to fight cancer
Jasper Booster - Woman cycling around the world to fight cancer by Alisen CharltenWednesday September 28, 2005 Manon Horwood sits also lost her mom to colon cancer at the age of 50
Manufacturer halts study of promising cancer drug
Chicago Sun-Times - that led to its approval in 2004 for colon cancer, but at a much lower rate than seen other than what it’s now licensed for — colon cancer, said Dr.
Genentech Stops Enrolling Avastin Study
San Francisco Chronicle - said Friday it stopped enrolling ovarian cancer patients in a mid-stage clinical study of Avastin due to drug last year for advanced colon cancer, but Avastin is also being